Anti-APOBEC3B antibody [EPR18138]
- RabMAb
- Recombinant
- What is this?
5
(3 Reviews)
|
(17 Publications)
Rabbit Recombinant Monoclonal APOBEC3B antibody. Suitable for WB and reacts with Transfected cell lysate - Human, Human samples. Cited in 17 publications.
View Alternative Names
DNA dC->dU-editing enzyme APOBEC-3B, A3B, Phorbolin-1-related protein, Phorbolin-2/3, APOBEC3B
- WB
Lab
Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
Negative sample : SK-BR-3 (PMID : 27634334).
Merged signal (red and green).
Green - ab184990 observed at 38 kDa.
Red - loading control, ab8245 observed at 36 kDa.
ab184990 Anti-APOBEC3B antibody [EPR18138] was shown to specifically react with APOBEC3B in wild-type HeLa cells. Loss of signal was observed when APOBEC3B CRISPR-Edited HeLa cell line was used. Wild-type and APOBEC3B CRISPR-Edited HeLa samples were subjected to SDS-PAGE.
ab184990 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively.
Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
APOBEC3B CRISPR-Edited HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 3:
A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
SK-BR-3 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Lanes 1 - 4:
Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution
Observed band size: 38 kDa
false
- WB
Lab
Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM /TBST We are unsure of the identity of the 55kda band.
All lanes:
Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/500 dilution
All lanes:
A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 46 kDa
Observed band size: 38 kDa
false
Exposure time: 180s
- WB
Collaborator
Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
Blocking buffer : 5% NFDM/TBST.
Dilution buffer : 1% NFDM/TBST.
Exposure time : Panel A : 20 s; Panel B : 1 min.
Figure provided by Dr. Jenni Nikkila. Gene Function Lab at The Institute of Cancer Research, London. HEK293-APOBEC3B(+GFP) tetracycline-inducible cell line provide by Dr Reuben Harris, University of Minnesota, Minneapolis - cited in Akre, M.K, G.J. Starrett, J.S. Quist, N.A. Temiz, M.A. Carpenter, A.N.J. Tutt, A. Grigoriadis & R.S. Harris (2016) Mutation processes in 293-based clones overexpressing the DNA cytosine deaminase APOBEC3B. PLoS One11(5) : e0155391. doi : 10.1371/journal.pone.0155391.
The 35 kDa band represents a known splice variant of APOBEC3B.
All lanes:
Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/10000 dilution
Lane 1:
HepaRG-APOBEC3B tetracycline-inducible cell line (+/-) at 20 µg
Lane 2:
HCC1143 cell line infected with control (+) and APOBEC3B lentivirus (-) at 20 µg
Lane 3:
HEK293-APOBEC3B(+GFP) tetracycline-inducible cell line (+/-) at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (H+L) conjugated to HRP at 1/10000 dilution
Predicted band size: 46 kDa
Observed band size: 35 kDa,70 kDa
false
- WB
Lab
Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
Exposure time : Lane 1-3 : 20 seconds; Lane 4-5 : 180 seconds
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.
ab184990 only detects very weak signal in HepG2 and HeLa cell lines.
All lanes:
Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/1000 dilution
Lane 1:
A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Lanes 2 and 4:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lanes 3 and 5:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 38 kDa
false
- WB
Supplier Data
Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/1000 dilution
Lane 1:
Human APOBEC3B fragment recombinant protein at 0.01 µg
Lane 2:
Human APOBEC3G fragment recombinant protein at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 46 kDa
Observed band size: 46 kDa
false
Related conjugates and formulations (1)
-
Anti-APOBEC3B antibody [EPR18138] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
APOBEC3B functions as part of the innate immune defense by restricting viral replication through inducing hypermutation in viral genomes. It does not form a stable complex but can act in conjunction with other APOBEC3 family members. APOBEC3B activity is critical in the context of host-virus interactions especially in the defense against retroviruses and other viruses.
Pathways
Scientists classify APOBEC3B within the viral restriction and DNA damage response pathways. In these pathways the protein works alongside other DNA repair proteins such as AID (Activation-Induced cytidine Deaminase). APOBEC3B participates in editing events that provide insights into virus-host co-evolution and resilience against viral infections.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Heliyon 10:e32139 PubMed38868014
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:348 PubMed37270643
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cancer research and clinical oncology 149:4639-4651 PubMed36175801
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature 607:799-807 PubMed35859169
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:658139 PubMed34660257
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 95:e0117021 PubMed34523960
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 49:7492-7506 PubMed34197599
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature genetics 52:884-890 PubMed32719516
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:2971 PubMed32532990
2020
Applications
Unspecified application
Species
Unspecified reactive species
NAR cancer 2:zcaa005 PubMed34316685
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com